From the Editor-in-Chief’s Desk: Benchmarking Clinically Meaningful Improvement in the Treatment of Tourette Syndrome

Abstract

Get full access to this article

View all access options for this article.

References

Bindseil

, Stutzman

, Schiel

, et al. Utility of aripiprazole in the treatment of anorexia nervosa in children and adolescents: A retrospective, descriptive, matched cohort study. J Child Adolesc Psychopharmacol, 2025; doi: 10.1089/cap.2025.0013

Can

, Vermilion

, Mink

, et al. Pharmacological treatment of tourette disorder in children. J Child Adolesc Psychopharmacol, 2024; 34(8):346–352; doi: 10.1089/cap.2023.0026

Farhat

, Behling

, Landeros-Weisenberger

, et al. Pharmacological interventions for attention-deficit/hyperactivity disorder in children and adolescents with tourette disorder: A systematic review and network meta-analysis. J Child Adolesc Psychopharmacol, 2024; 34(9):373–382; doi: 10.1089/cap.2024.0049

Macul Ferreira de Barros

, Farhat

, Behling

, et al. Systematic review and meta-analysis: Placebo response in randomized controlled trials of Tourette’s disorder medications. J Am Acad Child Adolesc Psychiatry, 2025; 64(5):577–592; doi: 10.1016/j.jaac.2024.10.011

McGuire

, Karkanias

, Bittman

, et al. Determining clinically meaningful improvement in children and adolescents with Tourette syndrome receiving pharmacotherapy. J Child Adolesc Psychopharmacol, 2025; doi: 10.1089/cap.2025.0036

Ray

, Fuchs

, Olfson

, et al. Incidence of neuroleptic malignant syndrome during antipsychotic treatment in children and youth: A national cohort study. J Child Adolesc Psychopharmacol, 2024; 34(9):397–406; doi: 10.1089/cap.2024.0047

Regenbogen-Li

, Rapp

. Letter: Seventeen-Year-Old develops neuroleptic malignant syndrome after brief low-dose exposure to aripiprazole: A case report. J Child Adolesc Psychopharmacol, 2025; doi: 10.1089/cap.2025.0055

Sanyal

, Lyu

, Calarge

, et al. Association between abnormal metabolic parameters and receiving subsequent interventions in children and adolescents initiating second-generation antipsychotics. J Child Adolesc Psychopharmacol, 2023; 33(7):269–278; doi: 10.1089/cap.2023.0027

Sapozhnikov

, Vermilion

. Co-Occurring anxiety in youth with tic disorders: A review. J Child Adolesc Psychopharmacol, 2023; 33(10):402–408; doi: 10.1089/cap.2022.0091

10.

Thorey

, Blanchet

, Guessoum

, et al. Efficacy and tolerance of second-generation antipsychotics in anorexia nervosa: A systematic scoping review. PLoS One, 2023; 18(3):e0278189; doi: 10.1371/journal.pone.0278189